The present invention provides methods for preventing retinal ganglion cell death in the glaucomatous eye and methods for suppressing apoptosis-specific eIF5A1 expression through the use of antisense oligonucleotides targeted to human apoptosis-specific eIF5A1.

 
Web www.patentalert.com

< Nucleic acids isolated from stage 4 neuroblastoma

> Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system
~ 00436